I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Addition of nintedanib or placebo to neoadjuvant gemcitabin..:
Hussain, Syed A
;
Lester, Jason F
;
Jackson, Richard
...
The Lancet Oncology. 23 (2022) 5 - p. 650-658 , 2022
Link:
https://doi.org/10.1016/s1470-2045(22)00158-9
RT Journal T1
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_s1470-2045(22)00158-9&Exemplar=1&LAN=DE A1 Hussain, Syed A A1 Lester, Jason F A1 Jackson, Richard A1 Gornall, Matthew A1 Qureshi, Muneeb A1 Elliott, Anthony A1 Crabb, Simon J A1 Huddart, Robert A A1 Vasudev, Naveen A1 Birtle, Alison J A1 Worlding, Jane A1 James, Nicholas D A1 Parikh, Omi A1 Vilarino-Varela, Maria A1 Alonzi, Roberto A1 Linch, Mark D A1 Riaz, Irbaz B A1 Catto, James W F A1 Powles, Thomas A1 Jones, Robert J PB Elsevier BV YR 2022 SN 1470-2045 JF The Lancet Oncology VO 23 IS 5 SP 650 OP 658 LK http://dx.doi.org/https://doi.org/10.1016/s1470-2045(22)00158-9 DO https://doi.org/10.1016/s1470-2045(22)00158-9 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)